Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A (301246.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100005ZB9

Price
15.81 CNY
Market cap
6.32 bn CNY
P/E (2025)
53.12
P/S (2025)
3.26
Dividend yield
0.32 %
Net margin
6.14 %
Return on equity (ROE)
2.67 %
Return on assets (ROA)
1.93 %

Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A financials

Fiscal year20242025
Revenue1.77 bn CNY1.94 bn CNY
Gross profit215.77 m CNY364.15 m CNY
Operating income86.11 m CNY178.41 m CNY
EBIT71.69 m CNY159.50 m CNY
Net income51.47 m CNY119.05 m CNY
Diluted EPS – continuing operations0.13 CNY0.30 CNY

Full history since 2021, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Hubei Hongyuan Pharmaceutical Technology Co. Ltd. A

Hubei Hongyuan Pharmaceutical Technology Co., Ltd., together with its subsidiaries, produces and sells pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients, such as metronidazole, benzoyl metronidazole, dimetrizole, and acyclovir; pharmaceutical intermediates, including imidazole, glyoxylic acid, 2-methyl imidazole, 2-methyl-5-nitroimidazole, sulfate, guanine, diacetyl guanine, and diacetylacyclovir; organic chemical raw materials comprising glyoxal, and oxalic acid; and new energy materials consisting of lithium hexafluorophosphate. It also is involved in the production and sales of triamines, guanine and other products; research and development, production, and sales of pharmaceutical preparations; trading of APIS, pharmaceutical intermediates, organic chemical raw materials, etc.; fluoride salts and other fluorine-containing chemical products; and pharmaceutical wholesale, retail, etc. Hubei Hongyuan Pharmaceutical Technology Co., Ltd. was founded in 2002 and is headquartered in Huanggang, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.